comparemela.com

Latest Breaking News On - Werfen - Page 10 : comparemela.com

US$ 87.9 billion, Point of Care (POC) Market is Estimated to Grow at a CAGR of 7.7% During the Estimated Time Frame from 2023 to 2029: Share to Cross 11.45% CAGR by 2029 – Global Report by Exactitude Consultancy Insights

Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed and published the final copy of

Bedfordshire
United-kingdom-general
United-kingdom
Malaysia
Japan
United-states
Argentina
Brazil
China
South-africa
Werfen
Nordrhein-westfalen

US$ 87.9 billion, Point of Care (POC) Market is Estimated

POC technology has the potential to improve patient diagnosis and treatment by allowing for faster access to test findings and, as a result, quicker.

Bedfordshire
United-kingdom-general
United-kingdom
Malaysia
Japan
United-states
Argentina
Brazil
China
South-africa
Werfen
Nordrhein-westfalen

Hemostasis Analyzers Global Market Report 2023

/PRNewswire/ Major players in the hemostasis analyzers market are Thermo Fisher Scientific Inc, Alere Inc, Siemens AG, F-Hoffmann La Roche, Nihon Kohden.

Germany
Australia
Japan
United-states
India
United-kingdom
Brazil
China
Werfen
Nordrhein-westfalen
Indonesia
South-korea

Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study

Although crude mortality did not differ between variants, adjusted risk of death was highest for patients treated with ECMO infected with the delta variant of SARS-CoV-2. The higher virulence and poorer outcomes associated with the delta strain might relate to higher viral load and increased inflammatory response syndrome in infected patients, reinforcing the need for a higher rate of vaccination in the population and updated selection criteria for ECMO, should a new and highly virulent strain of SARS-CoV-2 emerge in the future.

Spain
Werfen
Nordrhein-westfalen
Germany
Belgium
Italy
Portugal
Austria
France
Fisher-paykel
European-society-of-intensive-medicine
European-commission-horizon

With 10% CAGR, Autoimmune Disease Testing Market Size to

According to Fortune Business Insights, The Autoimmune Disease Testing Market size is anticipated to reach USD 10.75 billion by 2029, the market size was.

Germany
United-states
India
United-kingdom
Pune
Maharashtra
Werfen
Nordrhein-westfalen
Ireland
Canada
Switzerland
France

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.